New Delhi, June 30 -- Laurus Labs share price rose over 2% during Monday's trading session, marking the stock's third consecutive day of gains in a bullish trend. So far in June 2025, the stock has significantly outperformed the market with a rise of 18%, in contrast to the Sensex's 3% increase.

A recent report from AUM Research indicated that enhanced asset utilisation, fueled by project execution in the CDMO Operations segment along with new product launches in the FDF (Finished Dosage Forms), suggests that Laurus is poised for consistent growth in the future. The API segment is anticipated to rebound as prices stabilize and order books transition into sales.

(more to come)

Published by HT Digital Content Services with permission fro...